[{"id":"a0484239-01b6-477b-85f1-0b0d87f142ea","acronym":"","url":"https://clinicaltrials.gov/study/NCT03796390","created_at":"2023-08-14T10:11:00.531Z","updated_at":"2024-07-02T16:37:03.898Z","phase":"Phase 1","brief_title":"Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia","source_id_and_acronym":"NCT03796390","lead_sponsor":"Hebei Senlang Biotechnology Inc., Ltd.","biomarkers":" IL3RA","pipe":" | ","alterations":" CD123 positive • IL3RA positive","tags":["IL3RA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD123 positive • IL3RA positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SENL401"],"overall_status":"Unknown status","enrollment":" Enrollment 15","initiation":"Initiation: 12/26/2018","start_date":" 12/26/2018","primary_txt":" Primary completion: 11/06/2020","primary_completion_date":" 11/06/2020","study_txt":" Completion: 06/06/2021","study_completion_date":" 06/06/2021","last_update_posted":"2019-01-11"}]